Russell Investments Group’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$816K Sell
11,881
-20,654
-63% -$1.17M ﹤0.01% 2560
2026
Q1
$2.09M Sell
32,535
-42,360
-57% -$3.86M ﹤0.01% 1861
2025
Q4
$9.74M Sell
74,895
-4,052
-5% -$556K 0.01% 923
2025
Q3
$8.51M Sell
78,947
-2,008
-2% -$219K 0.01% 986
2025
Q2
$7.47M Sell
80,955
-27,413
-25% -$2.15M 0.01% 986
2025
Q1
$9.6M Buy
108,368
+2,955
+3% +$256K 0.01% 845
2024
Q4
$8.1M Sell
105,413
-74,985
-42% -$5.24M 0.01% 915
2024
Q3
$7.66M Buy
180,398
+35,469
+24% +$1.2M 0.01% 960
2024
Q2
$3.79M Buy
+144,929
New +$2.75M 0.01% 1285

Other funds holding WGS

Russell Investments Group's WGS Position: Q2 2026 in Review

Russell Investments Group reduced its GeneDx Holdings (WGS) stake by 63% in Q2 2026, selling an estimated $1.17M and leaving 11,881 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #2560.

Russell Investments Group first reported a position in WGS in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.74M in Q4 2025. 85 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Russell Investments Group held 11,881 shares of GeneDx Holdings worth $816K as of Q2 2026.
  • Russell Investments Group sold 20,654 GeneDx Holdings shares in Q2 2026, an estimated $1.17M.
  • GeneDx Holdings made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2560 holding.
  • Russell Investments Group first reported a position in GeneDx Holdings in Q2 2024 and has held it in 9 quarters since.
  • Russell Investments Group's GeneDx Holdings position peaked at $9.74M in Q4 2025.
  • 85 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.